Zhi‐Rong Tan
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Pharmacology 55
- Pharmacogenetics and Drug Metabolism 43
- Pharmacological Effects of Natural Compounds 13
- Drug-Induced Hepatotoxicity and Protection 11
- Oncology 34
- Drug Transport and Resistance Mechanisms 26
- Co-authors
- Hong‐Hao Zhou (27 shared papers)Yao Chen (41 shared papers)Hong‐Hao Zhou (20 shared papers)Lan Fan (16 shared papers)Dongsheng Ouyang (24 shared papers)Wei Zhang (21 shared papers)Dongli Hu (18 shared papers)Zhaoqian Liu (12 shared papers)
- Journals
- Xenobiotica (15 papers)European Journal of Clinical Pharmacology (13 papers)British Journal of Clinical Pharmacology (6 papers)Clinica Chimica Acta (4 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zhi‐Rong Tan
100 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 1.2k
- Complementary and alternative medicine 253
- Oncology 704
- Pharmacology 412
- Pediatrics, Perinatology and Child Health 372
Countries citing papers authored by Zhi‐Rong Tan
This map shows the geographic impact of Zhi‐Rong Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Rong Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Rong Tan more than expected).
Fields of papers citing papers by Zhi‐Rong Tan
This network shows the impact of papers produced by Zhi‐Rong Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Rong Tan. The network helps show where Zhi‐Rong Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhi‐Rong Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 197 | |
| 2 | 2008 | 137 | |
| 3 | 2019 | 109 | |
| 4 | 2011 | 98 | |
| 5 | 2006 | 84 | |
| 6 | 2019 | 75 | |
| 7 | 2009 | 70 | |
| 8 | 2017 | 69 | |
| 9 | 2005 | 66 | |
| 10 | 2002 | 65 | |
| 11 | 2003 | 63 | |
| 12 | 2020 | 60 | |
| 13 | 2001 | 57 | |
| 14 | 2018 | 56 | |
| 15 | 2010 | 56 | |
| 16 | 2007 | 52 | |
| 17 | 2009 | 47 | |
| 18 | 2010 | 46 | |
| 19 | 2003 | 44 | |
| 20 | 2008 | 43 |
About Zhi‐Rong Tan
Zhi‐Rong Tan is a scholar working on Pharmacology, Oncology, Molecular Biology, Pharmacology and Complementary and alternative medicine, having authored 103 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (43 papers), Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects of Natural Compounds (13 papers), Drug-Induced Hepatotoxicity and Protection (11 papers), Pharmacological Effects and Toxicity Studies (9 papers), Analytical Methods in Pharmaceuticals (8 papers), Ginseng Biological Effects and Applications (8 papers) and Traditional Chinese Medicine Analysis (7 papers). The work is most often cited by research in Pharmacology (1.2k citations), Complementary and alternative medicine (253 citations), Oncology (704 citations), Pharmacology (412 citations) and Pediatrics, Perinatology and Child Health (372 citations). Zhi‐Rong Tan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hong‐Hao Zhou, Yao Chen, Hong‐Hao Zhou, Lan Fan, Dongsheng Ouyang, Wei Zhang, Dongli Hu, Zhaoqian Liu, Gan Zhou and Yijing He. Their work appears in journals such as Xenobiotica, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Clinica Chimica Acta and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.